Scopus:
Carbon quantum dots conjugated rhodium nanoparticles as hybrid multimodal contrast agents

dc.contributor.authorSaladino G.M.
dc.contributor.authorKilic N.I.
dc.contributor.authorBrodin B.
dc.contributor.authorHamawandi B.
dc.contributor.authorYazgan I.
dc.contributor.authorHertz H.M.
dc.contributor.authorToprak M.S.
dc.date.accessioned2023-04-12T00:43:01Z
dc.date.available2023-04-12T00:43:01Z
dc.date.issued2021-09-01
dc.description.abstractNanoparticle (NP)‐based contrast agents enabling different imaging modalities are sought for non‐invasive bio‐diagnostics. A hybrid material, combining optical and X‐ray fluorescence is presented as a bioimaging contrast agent. Core NPs based on metallic rhodium (Rh) have been demonstrated to be potential X‐ray Fluorescence Computed Tomography (XFCT) contrast agents. Microwave‐assisted hydrothermal method is used for NP synthesis, yielding large‐scale NPs within a significantly short reaction time. Rh NP synthesis is performed by using a custom designed sugar ligand (LODAN), constituting a strong reducing agent in aqueous solution, which yields NPs with primary amines as surface functional groups. The amino groups on Rh NPs are used to directly conjugate excitation‐independent nitrogen‐doped carbon quantum dots (CQDs), which are synthesized through citrate pyrolysis in ammonia solution. CQDs provided the Rh NPs with optical fluorescence properties and improved their biocompatibility, as demonstrated in vitro by Real‐Time Cell Analysis (RTCA) on a macrophage cell line (RAW 264.7). The multimodal characteristics of the hybrid NPs are confirmed with confocal microscopy, and X‐ray Fluorescence (XRF) phantom ex-periments.
dc.identifier.doi10.3390/nano11092165
dc.identifier.scopus2-s2.0-85120871654
dc.identifier.urihttps://hdl.handle.net/20.500.12597/4361
dc.relation.ispartofNanomaterials
dc.rightstrue
dc.subjectBio‐imaging | Carbon quantum dots | Contrast agents | Dual‐mode imaging | Hybrid nanostructure | Nanomedicine | X‐ray fluorescence
dc.titleCarbon quantum dots conjugated rhodium nanoparticles as hybrid multimodal contrast agents
dc.typeArticle
dspace.entity.typeScopus
oaire.citation.issue9
oaire.citation.volume11
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.affiliation.nameKastamonu University
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.affiliation.nameThe Royal Institute of Technology (KTH)
person.identifier.scopus-author-id57215024544
person.identifier.scopus-author-id57226636426
person.identifier.scopus-author-id7003617049
person.identifier.scopus-author-id55779724300
person.identifier.scopus-author-id24554371300
person.identifier.scopus-author-id7103395653
person.identifier.scopus-author-id6603896825
relation.isPublicationOfScopusd682a6ae-e991-47fc-a988-e57217b2bfb7
relation.isPublicationOfScopus.latestForDiscoveryd682a6ae-e991-47fc-a988-e57217b2bfb7

Files